The Latest on COVID-19

• The Biden administration is expected to announce a plan to send 500 million Pfizer-BioNTech vaccines abroad, according to the Washington Post. This would be a significant increase to the number of vaccines that the administration has already pledged to send abroad. U.S. officials are now turning to battling the pandemic abroad as vaccination demand decreases at home.
• A new study shows that Johnson & Johnson’s COVID-19 vaccine initiates multiple immune responses, making it highly protective not only in the U.S., but also in Brazil and South Africa, where different coronavirus strains are circulating.
• Hundreds of thousands of Johnson & Johnson COVID-19 vaccines may expire before they can be administered, according to Kaiser Health News. While the vaccines can be redistributed to other areas in need, Johnson & Johnson and the FDA will also review new evidence to see whether the vaccine will remain viable after its initial expiration date.